XBiotech (XBIT) Invested Capital (2024)

XBiotech (XBIT) posted quarterly Invested Capital of $250000.0 for Q4 2024, down 97.5% quarter-over-quarter from $10.0 million in Q3 2024.

XBiotech (XBIT) Invested Capital (2024) Analysis & Trends

XBiotech's Invested Capital history runs 1 years deep, the most recent figure standing at $250000.0 for Q4 2024.

In Q4 2024, Invested Capital changed N/A year-over-year to $250000.0; the TTM figure through Sep 2025 stood at $250000.0 (down 99.17% YoY), while the FY2024 annual figure was $250000.0, changed N/A from the prior year.
Invested Capital for Q4 2024 stood at $250000.0, down from $10.0 million in the prior quarter.
The five-year high for Invested Capital was $10.0 million in Q1 2024, with the low at $250000.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	37.00 Mn
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	190.90 Mn
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	1.45 Bn
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	380.00 Mn
10	XBiotech	69.51 Mn	69.51 Mn	-	-

Download Data